KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Buildings: 2009-2010

Historic Buildings for Acadia Pharmaceuticals (ACAD) over the last 2 years, with Dec 2010 value amounting to $1.1 million.

  • Acadia Pharmaceuticals' Buildings fell 0.17% to $1.1 million in Q4 2010 from the same period last year, while for Dec 2010 it was $1.1 million, marking a year-over-year decrease of 0.17%. This contributed to the annual value of $1.1 million for FY2010, which is 0.17% down from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Buildings stood at $1.1 million for FY2010, which was down 0.17% from $1.1 million recorded in FY2009.
  • Acadia Pharmaceuticals' Buildings' 5-year high stood at $1.1 million during FY2009, with a 5-year trough of $1.1 million in FY2010.
  • For the 2-year period, Acadia Pharmaceuticals' Buildings averaged around $1.1 million, with its median value being $1.1 million (2009).
  • Data for Acadia Pharmaceuticals' Buildings shows a maximum YoY fell of 0.17% (in 2010) over the last 5 years.
  • Acadia Pharmaceuticals' Buildings (Yearly) stood at $1.1 million in 2009, then fell by 0.17% to $1.1 million in 2010.